| Schedule of Computation of Diluted Weighted Average Shares of Common Stock Outstanding |
The
following potentially dilutive securities, disaggregated by class, have been excluded from the computation of diluted weighted-average
shares of common stock outstanding, as they would be anti-dilutive, due to the reported losses:
Schedule
of Computation of Diluted Weighted Average Shares of Common Stock Outstanding
| | |
2026 | | |
2025 | |
| | |
Three Months Ended
March 31, | |
| | |
2026 | | |
2025 | |
| Redeemable convertible preferred stock | |
| 10,118,115 | | |
| 4,185,420 | |
| Convertible promissory notes | |
| - | | |
| 928,628 | |
| SAFEs | |
| - | | |
| 1,058,337 | |
| Common stock warrants | |
| - | | |
| - | |
| Secured Promissory Note Warrants | |
| - | | |
| 1,505,609 | |
| Service Provider Warrants | |
| 4,794,604 | | |
| - | |
| Placement Agent Warrants | |
| 36,822 | | |
| - | |
| Unvested restricted stock awards | |
| 27,000 | | |
| 1,520,760 | |
| Stock options | |
| 2,688,294 | | |
| 2,688,294 | |
| Total potentially dilutive shares | |
| 17,664,835 | | |
| 11,887,048 | |
|
The
following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares of common stock
outstanding, as they would be anti-dilutive, due to the reported losses:
Schedule
of Computation of Diluted Weighted Average Shares of Common Stock Outstanding
| | |
2025 | | |
2024 | |
| | |
December 31, | |
| | |
2025 | | |
2024 | |
| Redeemable convertible preferred stock | |
| 4,185,420 | | |
| 4,185,420 | |
| Convertible promissory notes | |
| 1,077,168 | | |
| 904,786 | |
| SAFEs | |
| 1,518,594 | | |
| 1,005,335 | |
| Common stock warrants | |
| 2,500,650 | | |
| 1,604,681 | |
| Unvested restricted stock awards | |
| 299,823 | | |
| 1,927,741 | |
| Stock options | |
| 2,688,294 | | |
| 2,920,881 | |
| Total potentially dilutive
shares | |
| 12,269,949 | | |
| 12,548,844 | |
|